What is the recommended treatment for excited delirium?

Treatment of Excited Delirium

For excited delirium, rapid sedation with antipsychotics such as haloperidol, olanzapine, or chlorpromazine is recommended as first-line treatment, with benzodiazepines added for refractory agitation that doesn't respond to antipsychotics alone. 1

Assessment and Recognition

Excited delirium presents as:

• Marked agitation and confusion
• Sympathomimetic surge (tachycardia, hypertension)
• Incessant physical struggle
• "Superhuman" strength
• Tolerance to significant pain
• Hyperthermia
• Profuse sweating
• Tachypnea
• Non-compliance with directions
• Lack of fatigue despite exertion 2, 3

Treatment Algorithm

Step 1: Immediate Stabilization

• Recognize excited delirium as a true medical emergency 3, 4
• Prioritize rapid, safe sedation to prevent metabolic derangements and sudden death 2
• Ensure a coordinated response between law enforcement and medical providers 3

Step 2: Pharmacological Management

For moderate agitation:

• Oral antipsychotics:
  • Haloperidol 2-5 mg
  • Risperidone 0.5-2 mg
  • Olanzapine 2.5-5 mg
  • Quetiapine 25-50 mg 1

For severe agitation/hyperactive delirium:

• Parenteral antipsychotics:
  • Haloperidol 2-5 mg IV/IM
  • Olanzapine 5-10 mg IM
  • Chlorpromazine (for bed-bound patients due to hypotensive effects) 1

For refractory agitation:

• Add benzodiazepines after therapeutic levels of neuroleptics:
  • Lorazepam 1-2 mg IV/IM
  • Midazolam 2.5-5 mg IM/IV 1, 3

Alternative approach in prehospital setting:

• Ketamine (4-5 mg/kg IM) has been shown to be effective and safe for rapid sedation in excited delirium 2, 3
  • Rapid onset (3-4 minutes)
  • Minimal respiratory depression
  • Maintains airway reflexes

Step 3: Address Underlying Causes

• Identify and treat reversible causes 1, 5
• Eliminate delirium-inducing medications (steroids, anticholinergics) 1, 5
• Consider opioid rotation if opioid neurotoxicity is suspected 1
• Provide supportive care:
  • Correct hyperthermia
  • Manage rhabdomyolysis
  • Address metabolic acidosis
  • Ensure adequate hydration 2, 3

Step 4: Non-Pharmacological Interventions

• Implement once patient is sufficiently sedated:
  • Reorientation strategies
  • Cognitive stimulation
  • Sleep hygiene
  • Early mobilization when stable
  • Create calm environment
  • Minimize unnecessary stimuli 1, 5

Important Considerations

• Avoid benzodiazepines as monotherapy except in alcohol or benzodiazepine withdrawal 1
• Monitor for side effects of antipsychotics:
  • QTc prolongation with haloperidol
  • Extrapyramidal symptoms
  • Hypotension with chlorpromazine 1
• Titrate medications to optimal relief while minimizing adverse effects 1
• Avoid physical restraints when possible as they may worsen delirium 5
• Provide 1:1 observation during acute phase 5

Special Situations

• Parkinson's disease or Lewy body dementia: Avoid haloperidol; consider quetiapine 5
• Alcohol or benzodiazepine withdrawal: Benzodiazepines are first-line treatment 1
• Opioid-associated delirium: Consider opioid rotation to methadone or fentanyl 1

Pitfalls to Avoid

• Failing to recognize excited delirium as a medical emergency
• Delaying sedation, which can lead to metabolic derangements and sudden death
• Using benzodiazepines alone (except in withdrawal states)
• Overlooking the need for supportive care after sedation
• Not monitoring for QTc prolongation with antipsychotics
• Assuming all agitation is excited delirium without considering other medical causes 3, 4, 6